Institutional members access full text with Ovid®

New Form, New Indication for Glycopyrrolate

Aschenbrenner, Diane S. MS, APRN-BC

AJN, American Journal of Nursing: November 2010 - Volume 110 - Issue 11 - p 24
doi: 10.1097/01.NAJ.0000390516.38146.b7
Drug Watch

* Glycopyrrolate has been approved in liquid form to treat drooling secondary to neurologic problems in children three to 16 years of age.

* Its adverse effects are similar to those of all anticholinergic drugs: dry mouth, constipation, flushing, and urinary retention.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2010 Lippincott Williams & Wilkins, Inc.